GoAI
Get started
Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

NASDAQHealthcareMedical - Healthcare Information Services

Open in GoAI

Previous close

$0.7141

−$0.0134 · -1.84%

Aug 21, 4:00 PM ET

Pre-market

$0.72

+$0.0059 · +0.83%

Aug 24, 8:31 AM ET

DH company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

47

Fair Value

Momentum

27

Weakening

Sentiment

63

Bullish

Risk resilience

26

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
Kevin D. Coop
Listed since
Sep 15, 2021
Employees
682

Market position

Day range

Current $0.7141

52-week range

Current $0.7141

Open
$0.705
Previous close
$0.7275
Volume
209.57K
0.62× average
Average volume
335.55K
Average daily volume
Market cap
75.35M USD
Beta
1.34
Market reference 1
50-day average
$0.7399
-3.48% below average
200-day average
$1.4728
-51.51% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
315.13M USD
P/E (TTM)
-0.45×
P/B (TTM)
0.52×
P/S (TTM)
0.32×
EV / EBITDA
-1.94×
Earnings yield
-45.39%
Free cash flow yield
12.11%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
71.67%
Operating margin
67.38%
Net margin
-72.28%
Return on equity
-49.42%
Return on assets
-18.89%
Return on invested capital
-3.32%

Financial health

Debt / equity
1.15×
Current ratio
1.64×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends117%-28%-173%-318%Gross margin, FY2021: 75.51%Gross margin, FY2022: 80.86%Gross margin, FY2023: 81.11%Gross margin, FY2024: 78.30%Gross margin, FY2025: 75.88%Operating margin, FY2021: -16.44%Operating margin, FY2022: -19.78%Operating margin, FY2023: -131.18%Operating margin, FY2024: -281.85%Operating margin, FY2025: -8.52%Net margin, FY2021: -31.24%Net margin, FY2022: -3.24%Net margin, FY2023: -80.50%Net margin, FY2024: -163.81%Net margin, FY2025: -57.52%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 75.51%. Gross margin FY2022 80.86%. Gross margin FY2023 81.11%. Gross margin FY2024 78.30%. Gross margin FY2025 75.88%. Operating margin FY2021 -16.44%. Operating margin FY2022 -19.78%. Operating margin FY2023 -131.18%. Operating margin FY2024 -281.85%. Operating margin FY2025 -8.52%. Net margin FY2021 -31.24%. Net margin FY2022 -3.24%. Net margin FY2023 -80.50%. Net margin FY2024 -163.81%. Net margin FY2025 -57.52%.

Income trends

Revenue

241.52M USD-4.24%

Operating income

−20.58M USD+97.10%

Net income

−138.93M USD+66.37%
Income trends across reported periods348.5M USD−36.7M USD−421.91M USD−807.12M USDRevenue, FY2021: 166.15M USDRevenue, FY2022: 222.65M USDRevenue, FY2023: 251.42M USDRevenue, FY2024: 252.2M USDRevenue, FY2025: 241.52M USDOperating income, FY2021: −27.32M USDOperating income, FY2022: −44.04M USDOperating income, FY2023: −329.8M USDOperating income, FY2024: −710.82M USDOperating income, FY2025: −20.58M USDNet income, FY2021: −51.91M USDNet income, FY2022: −7.22M USDNet income, FY2023: −202.39M USDNet income, FY2024: −413.12M USDNet income, FY2025: −138.93M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 166.15M USD. Revenue FY2022 222.65M USD. Revenue FY2023 251.42M USD. Revenue FY2024 252.2M USD. Revenue FY2025 241.52M USD. Operating income FY2021 −27.32M USD. Operating income FY2022 −44.04M USD. Operating income FY2023 −329.8M USD. Operating income FY2024 −710.82M USD. Operating income FY2025 −20.58M USD. Net income FY2021 −51.91M USD. Net income FY2022 −7.22M USD. Net income FY2023 −202.39M USD. Net income FY2024 −413.12M USD. Net income FY2025 −138.93M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue241.52M USD252.2M USD251.42M USD222.65M USD166.15M USD
Cost of goods sold58.25M USD54.73M USD47.48M USD42.63M USD40.69M USD
Gross profit183.28M USD197.47M USD203.93M USD180.03M USD125.47M USD
Research and development34.78M USD36.52M USD42.44M USD34.89M USD18.57M USD
Selling, general, and administrative133.26M USD133.07M USD153.4M USD141.15M USD89.25M USD
Operating expenses203.86M USD908.29M USD533.73M USD224.07M USD152.78M USD
Interest income6.95M USD14.59M USD13.64M USD2.79M USD29K USD
Interest expense11.29M USD14.84M USD15.2M USD11.2M USD25.9M USD
Depreciation and amortization35.82M USD51.67M USD51.75M USD56.9M USD59.95M USD
Operating income−20.58M USD−710.82M USD−329.8M USD−44.04M USD−27.32M USD
Net income−138.93M USD−413.12M USD−202.39M USD−7.22M USD−51.91M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
64%
7 beats, 0 misses, 4 met estimates
Average EPS surprise
+33.00%
11 comparable reports
Latest EPS result
0.05
Estimate 0.04 · Beat by 17.07%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.120.090.050.02Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MetQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 0.08, estimate 0.07, surprise +14.29%, Beat. Q2 2025, reported May 8, 2025: actual 0.05, estimate 0.02, surprise +150.00%, Beat. Q3 2025, reported Aug 7, 2025: actual 0.07, estimate 0.05, surprise +40.00%, Beat. Q4 2025, reported Nov 6, 2025: actual 0.07, estimate 0.06, surprise +16.67%, Beat. Q1 2026, reported Feb 26, 2026: actual 0.06, estimate 0.06, surprise 0.00%, Met estimate. Q2 2026, reported May 7, 2026: actual 0.06, estimate 0.03, surprise +100.00%, Beat. Q3 2026, reported Aug 10, 2026: actual 0.05, estimate 0.043, surprise +17.07%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.04, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates64.78M60.55M56.32M52.08MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 62.29M USD, estimate 60.59M USD, surprise +2.79%, Beat. Q2 2025, reported May 8, 2025: actual 59.19M USD, estimate 58.18M USD, surprise +1.73%, Beat. Q3 2025, reported Aug 7, 2025: actual 60.75M USD, estimate 59.24M USD, surprise +2.56%, Beat. Q4 2025, reported Nov 6, 2025: actual 60.05M USD, estimate 59.57M USD, surprise +0.81%, Beat. Q1 2026, reported Feb 26, 2026: actual 61.53M USD, estimate 59.61M USD, surprise +3.22%, Beat. Q2 2026, reported May 7, 2026: actual 55.93M USD, estimate 55.02M USD, surprise +1.65%, Beat. Q3 2026, reported Aug 10, 2026: actual 55.2M USD, estimate 55.47M USD, surprise -0.50%, Miss. Q4 2026, reported Nov 5, 2026: actual —, estimate 54.58M USD, surprise —, Comparison unavailable.

DH peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding DH

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
905.89K
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Inspire Small/Mid Cap ETF logoInspire Small/Mid Cap ETFISMD
Market value
594.66K
Weight
0.17%
AUM
349.35M USD
Expense ratio
0.53%
Price / 1D
$49.57+0.36%
iShares U.S. Small-Cap Equity Factor ETF logoiShares U.S. Small-Cap Equity Factor ETFSMLF
Market value
354.46K
Weight
0.01%
AUM
4.3B USD
Expense ratio
0.15%
Price / 1D
$89.29+0.80%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
325.91K
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
U.S. Micro Cap Portfolio ETF logoU.S. Micro Cap Portfolio ETFDFMC
Market value
199.93K
Weight
0.00%
AUM
8.06B USD
Expense ratio
0.43%
Price / 1D
$60.95+0.73%
Dimensional - US Core Equity 2 ETF logoDimensional - US Core Equity 2 ETFDFAC
Market value
145.89K
Weight
0.00%
AUM
49.31B USD
Expense ratio
0.17%
Price / 1D
$45.61+0.46%
Dimensional - US Small Cap ETF logoDimensional - US Small Cap ETFDFAS
Market value
145.77K
Weight
0.00%
AUM
15.92B USD
Expense ratio
0.26%
Price / 1D
$83.02+0.73%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
142.71K
Weight
0.00%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%

Continue in GoAI

Research DH

research.disclaimer